GoodRx Holdings, Inc.

GDRX

$3.39

Updated: 22/09/2026, 14:11:29

Market Cap

$1.18B

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

Stock valuation chart

One-year closing share-price history for GDRX

Company Profile

GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.

USD

NASDAQ

CEO: Wendy Barnes

Employees: 697

https://www.goodrx.com

Asset Summaries

Latest generated summaries for GDRX

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for GDRX.

Share price: $3.39
Market cap: $1.18B
Exchange: NASDAQ
Currency: USD
CEO: Wendy Barnes
Employees: 697
IPO date: 23/09/2020
Beta: 1.598
Last dividend: $0.00
Day range: $3.38 – $3.41
52-week range: $1.77 – $5.81
1-day performance: 0.30%
1-year performance: 91.53%
Current drawdown (1Y): -41.65%
CIK: 0001809519
CUSIP: 38246G108
ISIN: US38246G1085
Created: 07/12/2025, 04:11:43
Last update: 22/09/2026, 14:11:29

Track GoodRx Holdings, Inc. with an AI analyst

See which prediction-market events move GDRX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to GDRX from your Railway `news_articles` table.

GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade)

Seeking Alpha • STOCK • 20/05/2026, 13:46:57

GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 08/05/2026, 02:51:14

Big Pharma Runs Its Checkout Counter Through GoodRx

PYMNTS • STOCK • 07/05/2026, 15:08:28

GoodRx (GDRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research • STOCK • 06/05/2026, 22:31:11

GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates

Zacks Investment Research • STOCK • 06/05/2026, 21:35:51

GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients

Business Wire • STOCK • 01/05/2026, 10:10:00

Hims & Hers Expands Digital-First Access to Personalized Healthcare

Zacks Investment Research • STOCK • 29/04/2026, 13:31:19

GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call

Business Wire • STOCK • 17/04/2026, 18:05:00

GoodRx Holdings Inc. (NASDAQ:GDRX) Stock Update and Financial Overview

Market Data • Market Data • 26/02/2026, 22:10:27

GoodRx Targets Digital Subscription Growth Amid 14% Dip in Active Consumers

PYMNTS • STOCK • 26/02/2026, 12:40:37

Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings

Zacks Investment Research • STOCK • 26/02/2026, 11:31:32

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

Business Wire • STOCK • 05/02/2026, 20:44:00